Loading...
XJPX
4912
Market cap2.95bUSD
May 28, Last price  
1,562.00JPY
1D
-0.03%
1Q
-8.95%
Jan 2017
-18.65%
Name

Lion Corp

Chart & Performance

D1W1MN
P/E
20.03
P/S
1.03
EPS
77.98
Div Yield, %
1.73%
Shrs. gr., 5y
-0.96%
Rev. gr., 5y
3.51%
Revenues
412.94b
+2.53%
331,483,000,000330,229,000,000341,435,000,000338,383,000,000322,223,000,000331,278,000,000327,516,000,000335,076,000,000352,070,000,000367,475,000,000378,734,000,000395,667,000,000410,535,000,000349,403,000,000347,519,000,000355,352,000,000366,234,000,000389,869,000,000402,767,000,000412,943,000,000
Net income
21.20b
+44.95%
5,473,000,0005,540,000,0005,423,000,0003,040,000,0005,465,000,0006,041,000,0004,077,000,0004,235,000,0006,097,000,0007,368,000,00010,680,000,00015,951,000,00019,827,000,00025,606,000,00020,559,000,00029,870,000,00023,759,000,00021,939,000,00014,624,000,00021,197,000,000
CFO
43.66b
+45.20%
1,865,000,0003,343,000,00016,030,000,00015,183,000,00024,978,000,00025,518,000,00011,134,000,00018,762,000,00022,910,000,00011,738,000,00035,539,000,00032,269,000,00028,562,000,00031,879,000,00036,762,000,00040,729,000,00019,296,000,00041,962,000,00030,068,000,00043,660,000,000
Dividend
Jun 27, 20250 JPY/sh
Earnings
Aug 05, 2025

Profile

Lion Corporation manufactures and sells consumer and industrial products in Japan and internationally. It operates through three segments: Consumer Products Business, Industrial Products Business, and Overseas Business. The company offers dental and oral care products, including toothpastes, toothbrushes, dental floss, dental rinses, mouthwashes and breath fresheners, periodontitis ointments, and denture products; body care products, such as shampoos and conditioners, hand soaps, sanitizers, wet wipes, body washes, skin and acne care products, antiperspirants and deodorants, hair-nourishment treatments, men's care and toiletries products, and foot care products. It also provides antipyretic analgesics, eye drops and eye care products, cold medicines, gargles, cold relief products, topical anti-inflammatory analgesics, antidiarrheal and gastrointestinal medicines, health tonic drinks and vitamin supplements, acne and anti-drowsiness medicines, and dermatologic agents. In addition, the company offers fabric care products, such as laundry detergent, delicate detergent, prewash treatment, stain remover, bleach, and fabric softener; clothing care products; household cleaners; kitchen cleanup products comprises dishwashing detergents and antibacterial and deodorizing products; and food preparation products. Further, it provides health and beauty food products consisting of supplements and health tonic drinks; specialty chemicals, and chemical products, include rubber processing and additive agents, mandrel release agents, fatty acid methyl esters, plant-based electrical insulating oils, concrete admixtures, ground improvement and asphalt recycling agents, surfactants, and cosmetics ingredients, as well as electro-conductive carbon black and pressure-sensitive adhesives; pet supplies; and gift and special order products. The company was founded in 1891 and is headquartered in Tokyo, Japan.
URL
https://www.lion.co.jp/ja/
IPO date
May 16, 1949
Employees
7,587
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
412,943,000
2.53%
402,767,000
3.31%
389,869,000
6.45%
Cost of revenue
386,609,000
382,633,000
377,386,000
Unusual Expense (Income)
NOPBT
26,334,000
20,134,000
12,483,000
NOPBT Margin
6.38%
5.00%
3.20%
Operating Taxes
8,177,000
5,687,000
8,182,000
Tax Rate
31.05%
28.25%
65.55%
NOPAT
18,157,000
14,447,000
4,301,000
Net income
21,197,000
44.95%
14,624,000
-33.34%
21,939,000
-7.66%
Dividends
(7,289,000)
(7,385,000)
(6,895,000)
Dividend yield
1.49%
1.98%
1.60%
Proceeds from repurchase of equity
(10,002,000)
(1,000)
(10,001,000)
BB yield
2.05%
0.00%
2.32%
Debt
Debt current
2,099,000
2,191,000
3,179,000
Long-term debt
57,373,000
58,343,000
59,585,000
Deferred revenue
Other long-term liabilities
11,459,000
10,900,000
16,846,000
Net debt
(103,653,000)
(67,954,000)
(70,109,000)
Cash flow
Cash from operating activities
43,660,000
30,068,000
41,962,000
CAPEX
(18,062,000)
(23,723,000)
(23,145,000)
Cash from investing activities
(7,659,000)
(34,790,000)
(19,535,000)
Cash from financing activities
(21,205,000)
(11,762,000)
(19,821,000)
FCF
20,149,000
(3,996,000)
(31,265,000)
Balance
Cash
102,240,000
85,526,000
109,055,000
Long term investments
60,885,000
42,962,000
23,818,000
Excess cash
142,477,850
108,349,650
113,379,550
Stockholders' equity
269,347,000
274,883,000
256,028,000
Invested Capital
214,410,150
231,024,350
212,620,450
ROIC
8.15%
6.51%
2.19%
ROCE
7.38%
5.83%
3.80%
EV
Common stock shares outstanding
277,411
284,813
285,272
Price
1,762.50
34.70%
1,308.50
-13.57%
1,514.00
-1.50%
Market cap
488,937,474
31.20%
372,677,810
-13.71%
431,901,808
-3.50%
EV
407,260,474
322,540,810
376,704,808
EBITDA
47,496,000
40,335,000
30,148,000
EV/EBITDA
8.57
8.00
12.50
Interest
807,000
843,000
179,000
Interest/NOPBT
3.06%
4.19%
1.43%